(Q90602069)

English

TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib

scientific article published on 11 March 2020

In more languages
default for all languages
No label defined

No description defined

Statements

TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit